Introducing NEW HALO® Phases - 1,000 Å ES-C18 and 90 Å Biphenyl
Jul 04 2018 Read 823 Times
Advanced Material Technologies (AMT) have announced the brand-new HALO® 1,000 Å ES-C18 phase as part of their BioClass range of Fused-Core® HPLC columns! This unique phase is perfect for the separation of monoclonal antibodies, antibody-drug conjugates, and large proteins. Available in 2.7 µm and 3.4 µm particle sizes, the 1,000 Å ES-C18 exhibits low bleed making it ideal for your LC-MS applications. Perform HPLC and UHPLC separations on large biomolecules at moderate backpressures.
Additionally, AMT have also announced the HALO® 90 Å Biphenyl phase for the enhanced separation of aromatic compounds. This 2.7 µm Fused-Core® phase provides even greater retention of aromatic compounds than the HALO® Phenyl-Hexyl phase and can be used in highly aqueous conditions. HALO® 2.7 µm Fused-Core® columns can carry out UHPLC-like separations at lower backpressures than fully-porous sub-2 µm columns!
- NEW HALO® 1,000 Å ES-C18 phase for mAb, ADC, and large protein analysis.
- NEW HALO® 90 Å Biphenyl phase for separation of aromatic compounds.
- Fused-Core® technology for high-speed, high resolution, and highly reproducible separations.
- Suitable for HPLC and UHPLC instrumentation.
These new Fused-Core® phases are excellent additions to your method development arsenal. For further information on these exciting new phases from AMT, for more information on any Fused-Core® column, or to discuss converting your HPLC method to an ultra-fact method using solid-core particles, please contact the Hichrom technical team by email.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...
View all digital editions
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE
Jan 29 2020 Tokyo, Japan
Feb 03 2020 Dubai, UAE
Feb 12 2020 Tokyo, Japan